Clinuvel Pharmaceuticals Ltd
ASX:CUV

Watchlist Manager
Clinuvel Pharmaceuticals Ltd Logo
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Watchlist
Price: 12.1 AUD 0.83%
Market Cap: 605.7m AUD
Have any thoughts about
Clinuvel Pharmaceuticals Ltd?
Write Note

Wall Street
Price Targets

CUV Price Targets Summary
Clinuvel Pharmaceuticals Ltd

Wall Street analysts forecast CUV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CUV is 26.93 AUD with a low forecast of 17.17 AUD and a high forecast of 41.58 AUD.

Lowest
Price Target
17.17 AUD
42% Upside
Average
Price Target
26.93 AUD
123% Upside
Highest
Price Target
41.58 AUD
244% Upside
Clinuvel Pharmaceuticals Ltd Competitors:
Price Targets
688363
Bloomage Biotechnology Corp Ltd
7% Upside
358570
GI Innovation Inc
202% Upside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
15% Downside
2162
KeyMed Biosciences Inc
91% Upside
BVXP
Bioventix PLC
64% Upside
688105
Nanjing Vazyme Biotech Co Ltd
9% Upside
XNCR
Xencor Inc
39% Upside
ZYME
Zymeworks Inc
48% Upside

Revenue
Forecast

Revenue Estimate
Clinuvel Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 39%. The projected CAGR for the next 3 years is 16%.

39%
Past Growth
16%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Clinuvel Pharmaceuticals Ltd

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 10%.

N/A
Past Growth
10%
Estimated Growth
Estimates Accuracy
25%
Average Beat

Net Income
Forecast

Net Income Estimate
Clinuvel Pharmaceuticals Ltd

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
3%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CUV's stock price target?
Price Target
26.93 AUD

According to Wall Street analysts, the average 1-year price target for CUV is 26.93 AUD with a low forecast of 17.17 AUD and a high forecast of 41.58 AUD.

What is Clinuvel Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Clinuvel Pharmaceuticals Ltd's revenue is 39%. The projected CAGR for the next 3 years is 16%.

What is Clinuvel Pharmaceuticals Ltd's Operating Income forecast?
Projected CAGR
10%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's operating income for the next 3 years is 10%.

What is Clinuvel Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
20%

The compound annual growth rate of Clinuvel Pharmaceuticals Ltd's net income for the next 3 years is 20%.

Back to Top